Rachel Haring

1.3k total citations
37 papers, 1.0k citations indexed

About

Rachel Haring is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Rachel Haring has authored 37 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 22 papers in Cellular and Molecular Neuroscience and 7 papers in Physiology. Recurrent topics in Rachel Haring's work include Receptor Mechanisms and Signaling (26 papers), Neuroscience and Neuropharmacology Research (16 papers) and Alzheimer's disease research and treatments (7 papers). Rachel Haring is often cited by papers focused on Receptor Mechanisms and Signaling (26 papers), Neuroscience and Neuropharmacology Research (16 papers) and Alzheimer's disease research and treatments (7 papers). Rachel Haring collaborates with scholars based in Israel, United States and Netherlands. Rachel Haring's co-authors include Yoel Kloog, Abraham Fisher, Zipora Pittel, Eliahu Heldman, Mordechai Sokolovsky, David Gurwitz, Rachel Brandeis, Daniele Marciano, D. Manor and Claire M. Fraser and has published in prestigious journals such as Journal of Neuroscience, Biochemistry and Brain Research.

In The Last Decade

Rachel Haring

36 papers receiving 995 citations

Peers

Countries citing papers authored by Rachel Haring

Since Specialization

Citations

This map shows the geographic impact of Rachel Haring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Haring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Haring more than expected).

Fields of papers citing papers by Rachel Haring

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Haring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Haring. The network helps show where Rachel Haring may publish in the future.

Co-authorship network of co-authors of Rachel Haring

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Haring. A scholar is included among the top collaborators of Rachel Haring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Haring. Rachel Haring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	M<sub>1</sub> Muscarinic Agonists Can Modulate Some of the Hallmarks in Alzheimer's Disease: Implications in Future Therapy 2003 ·Journal of Molecular Neuroscience ·Abraham Fisher, Zipora Pittel, Rachel Haring, Nira Bar-Ner, (unknown), Niva Natan, (unknown), Hagar Sonego, (unknown), Rachel Brandeis	116
2	Impact of muscarinic agonists for successful therapy of Alzheimer’s disease 2002 ·Journal of neural transmission. Supplementum ·Abraham Fisher, Rachel Brandeis, Rachel Haring, Nira Bar-Ner, (unknown), Niva Natan, Hagar Sonego, (unknown), Zipora Pittel	11
3	M1 Muscarinic Agonists as Potential Disease‐Modifying Agents in Alzheimer's Disease: Rationale and Perspectives 2000 ·Annals of the New York Academy of Sciences ·Abraham Fisher, D. M. Michaelson, Rachel Brandeis, Rachel Haring, Shira Chapman, Zipora Pittel	53
4	Mitogen‐Activated Protein Kinase‐Dependent and Protein Kinase C‐Dependent Pathways Link the m1 Muscarinic Receptor to β‐Amyloid Precursor Protein Secretion 1998 ·Journal of Neurochemistry ·Rachel Haring, Abraham Fisher, Daniele Marciano, Zipora Pittel, Yoel Kloog, (unknown), Nomi Eshhar, Eliahu Heldman	110
5	Nerve Cell Death Induced by Ca2+ Ionophores in Dissociated Hippocampal Cultures 1997 ·Advances in experimental medicine and biology ·(unknown), Rachel Haring, Asher Shainberg, (unknown), Anthony H. Futerman, A. Shahar	1
6	Selective neurotoxicity induced by the ionophore lasalocid in rat dissociated cerebral cultures, involvement of the NMDA receptor/channel. 1997 ·PubMed ·(unknown), Rachel Haring, David Gurwitz, Asher Shainberg, (unknown), Andrew Levy, E. Bogin, A. Shahar	5
7	Dehydroepiandrosterone (DHEA) increases production and release of Alzheimer's amyloid precursor protein 1996 ·Life Sciences ·Haim Danenberg, Rachel Haring, Abraham Fisher, Zipora Pittel, David Gurwitz, Eliahu Heldman	16
8	M1 Agonists for the Treatment of Alzheimer's Disease. 1996 ·Annals of the New York Academy of Sciences ·Abraham Fisher, Eliahu Heldman, David Gurwitz, Rachel Haring, Yishai Karton, Haim Meshulam, Zipora Pittel, Daniele Marciano, Rachel Brandeis, Einat Sadot, (unknown), Ronit Pinkas‐Kramarski, Z. Vogel, Irith Ginzburg, (unknown), (unknown), (unknown), Amos D. Korczyn	61
9	Muscarinic control of amyloid precursor protein secretion in rat cerebral cortex and cerebellum 1996 ·Brain Research ·Zipora Pittel, Eliahu Heldman, Jacob Barg, Rachel Haring, Abraham Fisher	28
10	Dehydroepiandrosterone Augments M1‐Muscarinic Receptor‐Stimulated Amyloid Precursor Protein Secretion in Desensitized PC12M1 Cells 1995 ·Annals of the New York Academy of Sciences ·Haim Danenberg, Rachel Haring, Eliahu Heldman, David Gurwitz, D. Ben‐Nathan, Zipora Pittel, A. Zuckerman, Abraham Fisher	12
11	NGF Promotes Amyloid Precursor Protein Secretion via Muscarinic Receptor Activation 1995 ·Biochemical and Biophysical Research Communications ·Rachel Haring, David Gurwitz, Jacob Barg, (unknown), Eliahu Heldman, Zipora Pittel, Haim Danenberg, (unknown), Haim Meshulam, (unknown), Yishai Karton, Abraham Fisher	25
12	NGF-dependent neurotrophic-like effects of AF102B, anM1 Muscarinic agonist, in PC12M1 cells 1995 ·Neuroreport ·David Gurwitz, Rachel Haring, Ronit Pinkas‐Kramarski, Reuben D. Stein, Eliahu Heldman, Yishai Karton, Abraham Fisher	16
13	Selective neurotoxicity induced by lasalocid in dissociated cerebral cultures 1993 ·Toxicology in Vitro ·(unknown), Asher Shainberg, Rachel Haring, David Gurwitz, A. Shahar	2
14	High Efficiency Reconstitution of a Phencyclidine/MK-801 Receptor Binding Site Solubilized from Rat Forebrain Membranes 1991 ·Molecular Pharmacology ·Rachel Haring, Domenico E. Pellegrini‐Giampietro, Stephen R. Zukin, R. Suzanne Zukin, Mark A. Scheideler	2
15	Glycine‐Like Modulation of N‐Methyl‐d‐Aspartate Receptors by a Monoclonal Antibody That Enhances Long‐Term Potentiation 1991 ·Journal of Neurochemistry ·Rachel Haring, Patric K. Stanton, Mark A. Scheideler, Joseph R. Moskal	28
16	Comparison of ion-exchange high-performance liquid chromatography columns for purification of sendai virus integral membrane proteins 1989 ·Journal of Chromatography A ·Sytske Welling‐Wester, Rachel Haring, (unknown), Claes Örvell, G.W. Welling	6
17	Kinetic characterization of the phencyclidine-N-methyl-D-aspartate receptor interaction: evidence for a steric blockade of the channel 1988 ·Biochemistry ·Yoel Kloog, Rachel Haring, Mordechai Sokolovsky	100
18	Binding studies and photoaffinity labeling identify two classes of phenycyclidine receptors in rat brain 1987 ·Biochemistry ·Rachel Haring, Yoel Kloog, Asher Kalir, M Sokolovsky	35
19	Identification of polypeptides of the phencyclidine receptor of rat hippocampus by photoaffinity labeling with [3H]azidophencyclidine 1986 ·Biochemistry ·Rachel Haring, Yoel Kloog, Mordechai Sokolovsky	21
20	Multiple binding sites for phencyclidine on the nicotinic acetylcholine receptor from Torpedo ocellata electric organ 1984 ·Life Sciences ·Rachel Haring, Yoel Kloog	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact